{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:11:56Z","timestamp":1790176316623,"version":"4.1.0"},"publisher-location":"Cham","reference-count":69,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030462260","type":"print"},{"value":"9783030462277","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-46227-7_16","type":"book-chapter","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T19:02:50Z","timestamp":1599850970000},"page":"319-331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Sunlight, Vitamin D, and Xeroderma Pigmentosum"],"prefix":"10.1007","author":[{"given":"Marie Christine","family":"Martens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Emmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Boeckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"16_CR1","first-page":"1","volume":"38","author":"MC Martens","year":"2018","unstructured":"Martens MC, Seebode C, Lehmann J, Emmert S. Photocarcinogenesis and skin cancer prevention strategies: an update. Anticancer Res. 2018;38:1\u20136.","journal-title":"Anticancer Res"},{"key":"16_CR2","first-page":"1371","volume":"36","author":"C Seebode","year":"2016","unstructured":"Seebode C, Lehmann J, Emmert S. Photocarcinogenesis and skin cancer prevention strategies. Anticancer Res. 2016;36:1371\u20138.","journal-title":"Anticancer Res"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1011-1344(01)00245-7","volume":"65","author":"AA Vink","year":"2001","unstructured":"Vink AA, Roza L. Biological consequences of cyclobutane pyrimidine dimers. J Photochem Photobiol B. 2001;65:101\u20134.","journal-title":"J Photochem Photobiol B"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s00018-009-8737-y","volume":"66","author":"T Nouspikel","year":"2009","unstructured":"Nouspikel T. Nucleotide excision repair: variations on versatility. Cell Mol Life Sci. 2009;66:994\u20131009.","journal-title":"Cell Mol Life Sci"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.taap.2003.08.019","volume":"195","author":"Y Matsumura","year":"2004","unstructured":"Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol. 2004;195:298\u2013308.","journal-title":"Toxicol Appl Pharmacol"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0300-483X(03)00150-1","volume":"189","author":"M Ichihashi","year":"2003","unstructured":"Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, Tsuru K, Horikawa T. UV-induced skin damage. Toxicology. 2003;189:21\u201339.","journal-title":"Toxicology"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.jaad.2007.12.007","volume":"58","author":"L Marrot","year":"2008","unstructured":"Marrot L, Meunier J-R. Skin DNA photodamage and its biological consequences. J Am Acad Dermatol. 2008;58:S139\u201348.","journal-title":"J Am Acad Dermatol"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2017.05.001","volume":"453","author":"J Reichrath","year":"2017","unstructured":"Reichrath J, Saternus R, Vogt T. Endocrine actions of vitamin D in skin: relevance for photocarcinogenesis of non-melanoma skin cancer, and beyond. Mol Cell Endocrinol. 2017;453:96\u2013102.","journal-title":"Mol Cell Endocrinol"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12479237","volume":"77","author":"MF Holick","year":"1981","unstructured":"Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol. 1981;77:51\u20138.","journal-title":"J Invest Dermatol"},{"key":"16_CR10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.clindermatol.2016.05.004","volume":"34","author":"A Juzeniene","year":"2016","unstructured":"Juzeniene A, Grigalavicius M, Juraleviciute M, Grant WB. Phototherapy and vitamin D. Clin Dermatol. 2016;34:548\u201355.","journal-title":"Clin Dermatol"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/me.2011-1161","volume":"26","author":"VB Sequeira","year":"2012","unstructured":"Sequeira VB, Rybchyn MS, Tongkao-on W, Gordon-Thomson C, Malloy PJ, Nemere I, Norman AW, Reeve VE, Halliday GM, Feldman D, et al. The role of the vitamin D receptor and ERp57 in Photoprotection by 1\u03b1,25-Dihydroxyvitamin D 3. Mol Endocrinol. 2012;26:574\u201382.","journal-title":"Mol Endocrinol"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/nu2040408","volume":"2","author":"A Zittermann","year":"2010","unstructured":"Zittermann A, Gummert JF. Nonclassical vitamin D actions. Nutrients. 2010;2:408\u201325.","journal-title":"Nutrients"},{"key":"16_CR13","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1158\/1535-7163.MCT-11-0422","volume":"10","author":"A Uhmann","year":"2011","unstructured":"Uhmann A, Niemann H, Lammering B, Henkel C, He\u00df I, Nitzki F, Fritsch A, Pr\u00fcfer N, Rosenberger A, Dullin C, et al. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation. Mol Cancer Ther. 2011;10:2179\u201388.","journal-title":"Mol Cancer Ther"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1371\/journal.pbio.0040232","volume":"4","author":"MF Bijlsma","year":"2006","unstructured":"Bijlsma MF, Spek CA, Zivkovic D, Van De Water S, Rezaee F, Peppelenbosch MP. Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol. 2006;4:1397\u2013410.","journal-title":"PLoS Biol"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0043-123031","volume":"44","author":"J Lehmann","year":"2018","unstructured":"Lehmann J, Seebode C, Martens MC, Emmert S. Xeroderma pigmentosum \u2013 facts and perspectives. Aktuelle Derm. 2018;44:232\u20136.","journal-title":"Aktuelle Derm"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ejhg.2013.233","volume":"22","author":"S Schubert","year":"2014","unstructured":"Schubert S, Lehmann J, Kalfon L, Slor H, Falik-Zaccai TC, Emmert S. Clinical utility gene card for: Xeroderma pigmentosum. Eur J Hum Genet. 2014;22:953.","journal-title":"Eur J Hum Genet"},{"key":"16_CR17","first-page":"867","volume":"12","author":"J Lehmann","year":"2014","unstructured":"Lehmann J, Schubert S, Emmert S. Xeroderma pigmentosum: diagnostic procedures, interdisciplinary patient care, and novel therapeutic approaches. J Dtsch Dermatol Ges. 2014;12:867\u201372.","journal-title":"J Dtsch Dermatol Ges"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.mrfmmm.2006.06.010","volume":"601","author":"Y Hirai","year":"2006","unstructured":"Hirai Y, Kodama Y, Moriwaki SI, Noda A, Cullings HM, MacPhee DG, Kodama K, Mabuchi K, Kraemer KH, Land CE, et al. Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population. Mutat Res. 2006;601:171\u20138.","journal-title":"Mutat Res"},{"key":"16_CR19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/jid.2010.76","volume":"130","author":"D Tamura","year":"2010","unstructured":"Tamura D, Digiovanna JJ, Kraemer KH. Founder mutations in xeroderma pigmentosum. J Invest Dermatol. 2010;130:1491\u20133.","journal-title":"J Invest Dermatol"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/em.21716","volume":"53","author":"TC Falik-Zaccai","year":"2012","unstructured":"Falik-Zaccai TC, Erel-Segal R, Horev L, Bitterman-Deutsch O, Koka S, Chaim S, Keren Z, Kalfon L, Gross B, Segal Z, et al. A novel XPD mutation in a compound heterozygote; the mutation in the second allele is present in three homozygous patients with mild sun sensitivity. Environ Mol Mutagen. 2012;53:505\u201314.","journal-title":"Environ Mol Mutagen"},{"key":"16_CR21","first-page":"5656","volume":"55","author":"K Takayama","year":"1995","unstructured":"Takayama K, Salazar EP, Lehmann A, Stefanini M, Thompson LH, Weber CA. Defects in the DNA repair and transcription gene ERCC2 in the Cancer-prone disorder Xeroderma Pigmentosum group D. Cancer Res. 1995;55:5656\u201363.","journal-title":"Cancer Res"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"135.1","DOI":"10.1002\/9781444345384.ch135","volume-title":"Harper\u2019s textbook of pediatric dermatology","author":"S Emmert","year":"2011","unstructured":"Emmert S. Xeroderma pigmentosum, Cockayne\u2019s syndrome, and trichothiodystrophy. In: Irvine AD, Hoeger PH, Yan AC, editors. Harper\u2019s textbook of pediatric dermatology. Oxford: Wiley- Blackwell; 2011. p. 135.1\u2013135.24."},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jmg.2010.083022","volume":"48","author":"PT Bradford","year":"2011","unstructured":"Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, Oh KS, Imoto K, Inui H, Moriwaki SI, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48:168\u201376.","journal-title":"J Med Genet"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archderm.1994.01690080084012","volume":"130","author":"KH Kraemer","year":"1994","unstructured":"Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin Cancer: the Xeroderma Pigmentosum paradigm. Arch Dermatol. 1994;130:1018\u201321.","journal-title":"Arch Dermatol"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.survophthal.2011.03.001","volume":"56","author":"HL Ramkumar","year":"2011","unstructured":"Ramkumar HL, Brooks BP, Cao X, Tamura D, DiGiovanna JJ, Kraemer KH, Chan CC. Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature. Surv Ophthalmol. 2011;56:348\u201361.","journal-title":"Surv Ophthalmol"},{"key":"16_CR26","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/brain\/awn126","volume":"131","author":"A Anttinen","year":"2008","unstructured":"Anttinen A, Koulu L, Nikoskelainen E, Portin R, Kurki T, Erkinjuntti M, Jaspers NGJ, Raams A, Green MHL, Lehmann AR, et al. Neurological symptoms and natural course of xeroderma pigmentosum. Brain. 2008;131:1979\u201389.","journal-title":"Brain"},{"key":"16_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1101\/gad.859501","volume":"15","author":"AR Lehmann","year":"2001","unstructured":"Lehmann AR. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev. 2001;15:15\u201323.","journal-title":"Genes Dev"},{"key":"16_CR28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.molcel.2015.08.012","volume":"59","author":"C-L Li","year":"2015","unstructured":"Li C-L, Golebiowski FM, Onishi Y, Samara NL, Sugasawa K, Yang W. Tripartite DNA lesion recognition and verification by XPC, TFIIH, and XPA in nucleotide excision repair. Mol Cell. 2015;59:1025\u201334.","journal-title":"Mol Cell"},{"key":"16_CR29","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1074\/jbc.275.4.2532","volume":"275","author":"J Bradsher","year":"2000","unstructured":"Bradsher J, Coin F, Egly J-M. Distinct roles for the helicases of TFIIH in transcript initiation and promoter escape. J Biol Chem. 2000;275:2532\u20138.","journal-title":"J Biol Chem"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1074\/jbc.M116.747857","volume":"292","author":"D Das","year":"2017","unstructured":"Das D, Faridounnia M, Kovacic L, Kaptein R, Boelens R, Folkers GE. Single-stranded DNA binding by the helix-hairpin-helix domain of XPF protein contributes to the substrate specificity of the ERCC1-XPF protein complex. J Biol Chem. 2017;292:2842\u201353.","journal-title":"J Biol Chem"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s00018-017-2455-7","volume":"74","author":"J Lehmann","year":"2017","unstructured":"Lehmann J, Seebode C, Smolorz S, Schubert S, Emmert S. XPF knockout via CRISPR\/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF. Cell Mol Life Sci. 2017;74:2081\u201394.","journal-title":"Cell Mol Life Sci"},{"key":"16_CR32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/php.12641","volume":"93","author":"MG Kemp","year":"2017","unstructured":"Kemp MG, Hu J. PostExcision events in human nucleotide excision repair. Photochem Photobiol. 2017;93:178\u201391.","journal-title":"Photochem Photobiol"},{"key":"16_CR33","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1038\/sj.onc.1203842","volume":"19","author":"M Yuasa","year":"2000","unstructured":"Yuasa M, Masutani C, Eki T, Hanaoka F. Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene. Oncogene. 2000;19:4721\u20138.","journal-title":"Oncogene"},{"key":"16_CR34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.freeradbiomed.2018.12.012","volume":"131","author":"NC Moreno","year":"2019","unstructured":"Moreno NC, Garcia CCM, Munford V, Rocha CRR, Pelegrini AL, Corradi C, Sarasin A, Menck CFM. The key role of UVA-light induced oxidative stress in human Xeroderma Pigmentosum variant cells. Free Radic Biol Med. 2019;131:432\u201342.","journal-title":"Free Radic Biol Med"},{"key":"16_CR35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1684\/ejd.2010.0968","volume":"20","author":"M Hoesl","year":"2010","unstructured":"Hoesl M, Dietz K, R\u00f6cken M, Berneburg M. Vitamin D levels of XP-patients under stringent sun-protection. Eur J Derm. 2010;20:457\u201360.","journal-title":"Eur J Derm"},{"key":"16_CR36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/ijo.IJO_1319_18","volume":"67","author":"A Mohamed","year":"2019","unstructured":"Mohamed A, Bhargava A, Chaurasia S. Vitamin D supplementation in patients with xeroderma pigmentosum. Indian J Ophthalmol. 2019;67:308\u20139.","journal-title":"Indian J Ophthalmol"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ejcn.2015.1","volume":"69","author":"A Kuwabara","year":"2015","unstructured":"Kuwabara A, Tsugawa N, Tanaka K, Uejima Y, Ogawa J, Otao N, Yamada N, Masaki T, Nishigori C, Moriwaki S, et al. High prevalence of vitamin D deficiency in patients with xeroderma pigmetosum-A under strict sun protection. Eur J Clin Nutr. 2015;69:693\u20136.","journal-title":"Eur J Clin Nutr"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2230.2008.02865.x","volume":"34","author":"JT Ali","year":"2009","unstructured":"Ali JT, Mukasa Y, Coulson IH. Xeroderma pigmentosum: early diagnostic features and an adverse consequence of photoprotection. Clin Exp Dermatol. 2009;34:442\u20133.","journal-title":"Clin Exp Dermatol"},{"key":"16_CR39","first-page":"518","volume":"28","author":"NK Weisberg","year":"2002","unstructured":"Weisberg NK, Varghese M. Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream. Dermatol Surg. 2002;28:518\u201323.","journal-title":"Dermatol Surg"},{"key":"16_CR40","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1365-2133.2003.05613.x","volume":"149","author":"E Nagore","year":"2003","unstructured":"Nagore E, Sevila A, Sanmartin O, Botella-Estrada R, Requena C, Serra-Guillen C, Sanchez-PedreNo P, Guillen C. Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream. Br J Dermatol. 2003;149:858\u201361.","journal-title":"Br J Dermatol"},{"key":"16_CR41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2230.28.s1.10.x","volume":"28","author":"D Roseeuw","year":"2003","unstructured":"Roseeuw D. The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum. Clin Exp Dermatol. 2003;28:30\u20132.","journal-title":"Clin Exp Dermatol"},{"key":"16_CR42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2230.28.s1.11.x","volume":"28","author":"B Giannotti","year":"2003","unstructured":"Giannotti B, Vanzi L, Difonzo EM, Pimpinelli N. The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin. Clin Exp Dermatol. 2003;28:33\u20135.","journal-title":"Clin Exp Dermatol"},{"key":"16_CR43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaad.2004.06.034","volume":"52","author":"T Nijsten","year":"2005","unstructured":"Nijsten T, Lapi\u00e8re K, Lambert J. A patient with xeroderma pigmentosum treated with imiquimod 5% cream. J Am Acad Dermatol. 2005;52:169\u201370.","journal-title":"J Am Acad Dermatol"},{"key":"16_CR44","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1525-1470.2008.00727.x","volume":"25","author":"AK Malhotra","year":"2008","unstructured":"Malhotra AK, Gupta S, Khaitan BK, Verma KK. Multiple basal cell carcinomas in xeroderma pigmentosum treated with imiquimod 5% cream. Pediatr Dermatol. 2008;25:488\u201391.","journal-title":"Pediatr Dermatol"},{"key":"16_CR45","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1590\/S1807-59322009001000005","volume":"64","author":"SS Alessi","year":"2009","unstructured":"Alessi SS, Sanches JA, de Oliveira WR, Messina MC, de Almeida Pimentel ER, Neto CF. Treatment of cutaneous tumors with topical 5% imiquimod cream. Clinics. 2009;64:961\u20136.","journal-title":"Clinics"},{"key":"16_CR46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/dth.12217","volume":"28","author":"JQ Yang","year":"2015","unstructured":"Yang JQ, Chen XY, Engle MY, Wang JY. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream. Dermatol Ther. 2015;28:243\u20137.","journal-title":"Dermatol Ther"},{"key":"16_CR47","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1111\/jdv.14818","volume":"32","author":"I Latour","year":"2018","unstructured":"Latour I, Hern\u00e1ndez-Mart\u00edn A, Ged C, Kn\u00f6pfel N, Ta\u00efeb A, Torrelo A. Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod. J Eur Acad Dermatol Venereol. 2018;32:e282\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"16_CR48","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ijd.13235","volume":"55","author":"E Hanna","year":"2016","unstructured":"Hanna E, Abadi R, Abbas O. Imiquimod in dermatology: an overview. Int J Dermatol. 2016;55:831\u201344.","journal-title":"Int J Dermatol"},{"key":"16_CR49","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1073\/pnas.72.10.4071","volume":"72","author":"K Tanaka","year":"1975","unstructured":"Tanaka K, Sekiguchi M, Okada Y. Restoration of ultraviolet-induced unscheduled DNA synthesis of xeroderma pigmentosum cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus). Proc Natl Acad Sci. 1975;72:4071\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"16_CR50","first-page":"405","volume":"7","author":"S Zahid","year":"2008","unstructured":"Zahid S, Brownell I. Repairing DNA damage in xeroderma pigmentosum: T4N5 lotion and gene therapy. J Drugs Dermatol. 2008;7:405\u20138.","journal-title":"J Drugs Dermatol"},{"key":"16_CR51","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1111\/jdv.14209","volume":"31","author":"E Moscarella","year":"2017","unstructured":"Moscarella E, Argenziano G, Longo C, Aladren S. Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study. J Eur Acad Dermatol Venereol. 2017;31:e401\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"16_CR52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrc2503","volume":"8","author":"EH Epstein","year":"2008","unstructured":"Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008;8:743\u201354.","journal-title":"Nat Rev Cancer"},{"key":"16_CR53","first-page":"33","volume":"9","author":"EY-X Tay","year":"2018","unstructured":"Tay EY-X, Teoh Y-L, Yeo MS-W. Hedgehog pathway inhibitors and their utility in basal cell carcinoma: a comprehensive review of current evidence. Dermatol Ther (Heidelb). 2018;9:33\u201349.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"16_CR54","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1021\/ol900974u","volume":"11","author":"JD Winkler","year":"2009","unstructured":"Winkler JD, Isaacs A, Holderbaum L, Tatard V, Dahmane N. Design and synthesis of inhibitors of hedgehog signaling based on the alkaloid Cyclopamine. Org Lett. 2009;11:2824\u20137.","journal-title":"Org Lett"},{"key":"16_CR55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/pde.13080","volume":"34","author":"D Fife","year":"2017","unstructured":"Fife D, Laitinen MA, Myers DJ, Landsteiner PB. Vismodegib therapy for basal cell carcinoma in an 8-year-old Chinese boy with Xeroderma Pigmentosum. Pediatr Dermatol. 2017;34:163\u20135.","journal-title":"Pediatr Dermatol"},{"key":"16_CR56","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/pde.13610","volume":"35","author":"E Soura","year":"2018","unstructured":"Soura E, Plaka M, Dessinioti C, Chasapi V, Stefanaki C, Antoniou C, Stratigos A. Use of vismodegib for the treatment of multiple basal cell carcinomas in a patient with xeroderma pigmentosum. Pediatr Dermatol. 2018;35:e334\u20136.","journal-title":"Pediatr Dermatol"},{"key":"16_CR57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/med.21530","volume":"39","author":"J Yang","year":"2019","unstructured":"Yang J, Hu L. Immunomodulators targeting the PD-1\/PD-L1 protein-protein interaction: from antibodies to small molecules. Med Res Rev. 2019;39:265\u2013301.","journal-title":"Med Res Rev"},{"key":"16_CR58","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bjd.16270","volume":"178","author":"G Salomon","year":"2018","unstructured":"Salomon G, Maza A, Boulinguez S, Paul C, Lamant L, Tournier E, Mazereeuw-Hautier J, Meyer N. Efficacy of anti-programmed cell death-1 immunotherapy for skin carcinomas and melanoma metastases in a patient with xeroderma pigmentosum. Br J Dermatol. 2018;178:1199\u2013203.","journal-title":"Br J Dermatol"},{"key":"16_CR59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2017.02.026","volume":"77","author":"A Hauschild","year":"2017","unstructured":"Hauschild A, Eichstaedt J, M\u00f6bus L, K\u00e4hler K, Weichenthal M, Schwarz T, Weidinger S. Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab. Eur J Cancer. 2017;77:84\u20137.","journal-title":"Eur J Cancer"},{"key":"16_CR60","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1529-8019.2006.00088.x","volume":"19","author":"RM Campbell","year":"2006","unstructured":"Campbell RM, DiGiovanna JJ. Skin cancer chemoprevention with systemic retinoids: an adjunct in the management of selected high-risk patients. Dermatol Ther. 2006;19:306\u201314.","journal-title":"Dermatol Ther"},{"key":"16_CR61","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM198806233182501","volume":"318","author":"KH Kraemer","year":"1988","unstructured":"Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin Cancer in Xeroderma Pigmentosum with the use of Oral Isotretinoin. N Engl J Med. 1988;318:1633\u20137.","journal-title":"N Engl J Med"},{"key":"16_CR62","doi-asserted-by":"crossref","first-page":"19483","DOI":"10.1073\/pnas.1312088110","volume":"110","author":"C Kuschal","year":"2013","unstructured":"Kuschal C, DiGiovanna JJ, Khan SG, Gatti RA, Kraemer KH. Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons. Proc Natl Acad Sci. 2013;110:19483\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"16_CR63","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/exd.12655","volume":"24","author":"C Kuschal","year":"2015","unstructured":"Kuschal C, Khan SG, Enk B, DiGiovanna JJ, Kraemer KH. Readthrough of stop codons by use of aminoglycosides in cells from xeroderma pigmentosum group C patients. Exp Dermatol. 2015;24:296\u20137.","journal-title":"Exp Dermatol"},{"key":"16_CR64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.molcel.2017.10.021","volume":"68","author":"A Mazouzi","year":"2017","unstructured":"Mazouzi A, Battistini F, Moser SC, Ferreira da Silva J, Wiedner M, Owusu M, Lardeau C-H, Ringler A, Weil B, Neesen J, et al. Repair of UV-induced DNA damage independent of nucleotide excision repair is masked by MUTYH. Mol Cell. 2017;68:797\u2013807.e7","journal-title":"Mol Cell"},{"key":"16_CR65","first-page":"783","volume":"15","author":"J Lehmann","year":"2017","unstructured":"Lehmann J, Seebode C, Emmert S. Research on genodermatoses using novel genome-editing tools. JDDG J Ger Soc Dermatol. 2017;15:783\u20139.","journal-title":"JDDG J Ger Soc Dermatol"},{"key":"16_CR66","doi-asserted-by":"crossref","first-page":"e78678","DOI":"10.1371\/journal.pone.0078678","volume":"8","author":"A Dupuy","year":"2013","unstructured":"Dupuy A, Valton J, Leduc S, Armier J, Galetto R, Gouble A, Lebuhotel C, Stary A, P\u00e2ques F, Duchateau P, et al. Targeted gene therapy of Xeroderma Pigmentosum cells using Meganuclease and TALEN\u2122. PLoS One. 2013;8:e78678.","journal-title":"PLoS One"},{"key":"16_CR67","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/mt.2011.233","volume":"20","author":"E Warrick","year":"2012","unstructured":"Warrick E, Garcia M, Chagnoleau C, Chevallier O, Bergoglio V, Sartori D, Mavilio F, Angulo JF, Avril M-F, Sarasin A, et al. Preclinical corrective gene transfer in Xeroderma Pigmentosum human skin stem cells. Mol Ther. 2012;20:798\u2013807.","journal-title":"Mol Ther"},{"issue":"22","key":"16_CR68","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1111\/bph.14557","volume":"176","author":"R Abeti","year":"2019","unstructured":"Abeti R, Zeitlberger A, Peelo C, Fassihi H, Sarkany RPE, Lehmann AR, Giunti P. Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms. Br J Pharmacol. 2019;176(22):4293\u2013301.","journal-title":"Br J Pharmacol"},{"key":"16_CR69","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature19329","volume":"537","author":"WP Vermeij","year":"2016","unstructured":"Vermeij WP, Doll\u00e9 MET, Reiling E, Jaarsma D, Payan-Gomez C, Bombardieri CR, Wu H, Roks AJM, Botter SM, Van Der Eerden BC, et al. Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice. Nature. 2016;537:427\u201331.","journal-title":"Nature"}],"container-title":["Advances in Experimental Medicine and Biology","Sunlight, Vitamin D and Skin Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-46227-7_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T19:23:44Z","timestamp":1599852224000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-46227-7_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030462260","9783030462277"],"references-count":69,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-46227-7_16","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"12 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}